Hutamekalin Pilaiwanwadee, Saito Takayuki, Yamaki Kouya, Mizutani Nobuaki, Brand David D, Waritani Takaki, Terato Kuniaki, Yoshino Shin
Department of Pharmacology, Kobe Pharmaceutical University, Kobe-shi, Hyogo-ken, Japan.
J Immunol Methods. 2009 Mar 31;343(1):49-55. doi: 10.1016/j.jim.2009.01.009.
A cocktail of 4 monoclonal anti-type II collagen antibodies recognizing conserved epitopes located within the CB11 fragment (CII 124-402) of type II collagen is currently used as an arthritogenic antibody preparation for inducing collagen antibody induced arthritis (CAIA). In order to increase the arthritogenicity of this cocktail, we have developed 7 new monoclonal antibodies to anti-type II collagen from spleen cells of DBA/1J mice immunized with bovine type II collagen, and tested for their additional effect on the arthritogenicity over that of the current 4-clone cocktail. Three of the clones (CII-3, -5 and -6) bind to the LyC1 (CII 124-290) peptide of CB11 and 1 (CII-7) of the clones binds to CB9.7 (CII 898-1020), and highly cross-reacted with other species of type II collagen. This indicates that these clones recognize conserved epitopes within type II collagen, including mouse type II collagen. On the other hand, 2 other clones (CII-1 and -4) directed against CB9.7 and 1 clone (CII-2) against CB8 (CII 403-551) were less reactive with other species of type II collagen. The arthritogenicity of the current 4-clone cocktail was significantly increased by addition of a fifth clone, CII-3. No effects were observed with other clones. The arthritogenicity of this new 5-clone cocktail was 2-fold greater than the current 4-clone cocktail in all strains of mice tested: the CIA-responder strain DBA/1J, the CIA-resistant BALB/c (H-2(d)), the T-cell deficient C.B-17/l scid/scid and the CAIA-low responder C57BL/6 (H-2(b)) strain. These results clearly indicated the importance of epitope specificity of arthritogenicity of autoantibodies to type II collagen. Due to its enhanced arthritogenicity, this 5-clone cocktail is capable of inducing a more consistent and severe arthritis with lower doses compared to the current 4-clone cocktail, and will provide an effective new reagent for inducing arthritis in various strains of CAIA low responder mice.
一种由4种单克隆抗II型胶原抗体组成的混合物,可识别位于II型胶原CB11片段(CII 124 - 402)内的保守表位,目前被用作致关节炎抗体制剂来诱导胶原抗体诱导的关节炎(CAIA)。为了增强这种混合物的致关节炎性,我们从用牛II型胶原免疫的DBA/1J小鼠的脾细胞中开发了7种新的抗II型胶原单克隆抗体,并测试了它们对当前4克隆混合物致关节炎性的额外影响。其中3个克隆(CII - 3、- 5和- 6)与CB11的LyC1(CII 124 - 290)肽结合,1个克隆(CII - 7)与CB9.7(CII 898 - 1020)结合,并与其他物种的II型胶原高度交叉反应。这表明这些克隆识别II型胶原内的保守表位,包括小鼠II型胶原。另一方面,另外2个针对CB9.7的克隆(CII - 1和- 4)以及1个针对CB8(CII 403 - 551)的克隆(CII - 2)与其他物种的II型胶原反应性较低。加入第五个克隆CII - 3后,当前4克隆混合物诱导关节炎的能力显著增强。其他克隆则未观察到效果。在所有测试的小鼠品系中:CIA反应品系DBA/1J、CIA抗性品系BALB/c(H - 2(d))、T细胞缺陷品系C.B - 17/l scid/scid和CAIA低反应品系C57BL/6(H - 2(b)),这种新的5克隆混合物诱导关节炎的能力比当前4克隆混合物高2倍。这些结果清楚地表明了自身抗体对II型胶原致关节炎性的表位特异性的重要性。由于其增强的致关节炎性,与当前I4克隆混合物相比,这种5克隆混合物能够以更低剂量诱导更一致、更严重的关节炎,并将为在各种CAIA低反应小鼠品系中诱导关节炎提供一种有效的新试剂。